Abstract
Summary
According to our LPI (LP Information) latest study, the global Drug Discovery Software market size was valued at US$ 174.1 million in 2023. With growing demand in downstream market, the Drug Discovery Software is forecast to a readjusted size of US$ 359.1 million by 2030 with a CAGR of 10.9% during review period.
The research report highlights the growth potential of the global Drug Discovery Software market. Drug Discovery Software are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Discovery Software. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Discovery Software market.
Drug Discovery Software is a type of software that helps researchers and scientists to design, test, and optimize potential new drugs using computational methods and data analysis. Drug Discovery Software can provide features such as molecular modeling, virtual screening, docking, pharmacophore analysis, QSAR, ADMET prediction, and cheminformatics . Drug Discovery Software aims to help researchers and scientists accelerate the drug discovery process, reduce the cost and risk of failure, and discover novel and effective therapeutics .
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Drug Discovery Software market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Discovery Software market. It may include historical data, market segmentation by Type (e.g., Cloud Based, Web Based), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Discovery Software market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Discovery Software market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Discovery Software industry. This include advancements in Drug Discovery Software technology, Drug Discovery Software new entrants, Drug Discovery Software new investment, and other innovations that are shaping the future of Drug Discovery Software.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Discovery Software market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Discovery Software product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Discovery Software market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Discovery Software market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Discovery Software market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Discovery Software industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Discovery Software market.
Market Segmentation:
Drug Discovery Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Cloud Based
Web Based
Segmentation by application
CROs and Universities
Companies
Testing Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Epocrates
MicroTracker
DrugPatentWatch
PEPID PDC
AtomWise
InSilicoTrials
Thermo Scientific
AutoDock
CCD Vault
Compound Assist
DrugDev Spark
DSG Drug Safety
The research report highlights the growth potential of the global Drug Discovery Software market. Drug Discovery Software are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Discovery Software. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Discovery Software market.
Drug Discovery Software is a type of software that helps researchers and scientists to design, test, and optimize potential new drugs using computational methods and data analysis. Drug Discovery Software can provide features such as molecular modeling, virtual screening, docking, pharmacophore analysis, QSAR, ADMET prediction, and cheminformatics . Drug Discovery Software aims to help researchers and scientists accelerate the drug discovery process, reduce the cost and risk of failure, and discover novel and effective therapeutics .
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Drug Discovery Software market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Discovery Software market. It may include historical data, market segmentation by Type (e.g., Cloud Based, Web Based), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Discovery Software market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Discovery Software market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Discovery Software industry. This include advancements in Drug Discovery Software technology, Drug Discovery Software new entrants, Drug Discovery Software new investment, and other innovations that are shaping the future of Drug Discovery Software.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Discovery Software market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Discovery Software product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Discovery Software market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Discovery Software market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Discovery Software market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Discovery Software industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Discovery Software market.
Market Segmentation:
Drug Discovery Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Cloud Based
Web Based
Segmentation by application
CROs and Universities
Companies
Testing Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Epocrates
MicroTracker
DrugPatentWatch
PEPID PDC
AtomWise
InSilicoTrials
Thermo Scientific
AutoDock
CCD Vault
Compound Assist
DrugDev Spark
DSG Drug Safety
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Discovery Software Market Size 2019-2030
2.1.2 Drug Discovery Software Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Discovery Software Segment by Type
2.2.1 Cloud Based
2.2.2 Web Based
2.3 Drug Discovery Software Market Size by Type
2.3.1 Drug Discovery Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Discovery Software Market Size Market Share by Type (2019-2024)
2.4 Drug Discovery Software Segment by Application
2.4.1 CROs and Universities
2.4.2 Companies
2.4.3 Testing Labs
2.5 Drug Discovery Software Market Size by Application
2.5.1 Drug Discovery Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Discovery Software Market Size Market Share by Application (2019-2024)
3 Drug Discovery Software Market Size by Player
3.1 Drug Discovery Software Market Size Market Share by Players
3.1.1 Global Drug Discovery Software Revenue by Players (2019-2024)
3.1.2 Global Drug Discovery Software Revenue Market Share by Players (2019-2024)
3.2 Global Drug Discovery Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Software by Regions
4.1 Drug Discovery Software Market Size by Regions (2019-2024)
4.2 Americas Drug Discovery Software Market Size Growth (2019-2024)
4.3 APAC Drug Discovery Software Market Size Growth (2019-2024)
4.4 Europe Drug Discovery Software Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug Discovery Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drug Discovery Software Market Size by Country (2019-2024)
5.2 Americas Drug Discovery Software Market Size by Type (2019-2024)
5.3 Americas Drug Discovery Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Discovery Software Market Size by Region (2019-2024)
6.2 APAC Drug Discovery Software Market Size by Type (2019-2024)
6.3 APAC Drug Discovery Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Discovery Software by Country (2019-2024)
7.2 Europe Drug Discovery Software Market Size by Type (2019-2024)
7.3 Europe Drug Discovery Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Discovery Software by Region (2019-2024)
8.2 Middle East & Africa Drug Discovery Software Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Discovery Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Discovery Software Market Forecast
10.1 Global Drug Discovery Software Forecast by Regions (2025-2030)
10.1.1 Global Drug Discovery Software Forecast by Regions (2025-2030)
10.1.2 Americas Drug Discovery Software Forecast
10.1.3 APAC Drug Discovery Software Forecast
10.1.4 Europe Drug Discovery Software Forecast
10.1.5 Middle East & Africa Drug Discovery Software Forecast
10.2 Americas Drug Discovery Software Forecast by Country (2025-2030)
10.2.1 United States Drug Discovery Software Market Forecast
10.2.2 Canada Drug Discovery Software Market Forecast
10.2.3 Mexico Drug Discovery Software Market Forecast
10.2.4 Brazil Drug Discovery Software Market Forecast
10.3 APAC Drug Discovery Software Forecast by Region (2025-2030)
10.3.1 China Drug Discovery Software Market Forecast
10.3.2 Japan Drug Discovery Software Market Forecast
10.3.3 Korea Drug Discovery Software Market Forecast
10.3.4 Southeast Asia Drug Discovery Software Market Forecast
10.3.5 India Drug Discovery Software Market Forecast
10.3.6 Australia Drug Discovery Software Market Forecast
10.4 Europe Drug Discovery Software Forecast by Country (2025-2030)
10.4.1 Germany Drug Discovery Software Market Forecast
10.4.2 France Drug Discovery Software Market Forecast
10.4.3 UK Drug Discovery Software Market Forecast
10.4.4 Italy Drug Discovery Software Market Forecast
10.4.5 Russia Drug Discovery Software Market Forecast
10.5 Middle East & Africa Drug Discovery Software Forecast by Region (2025-2030)
10.5.1 Egypt Drug Discovery Software Market Forecast
10.5.2 South Africa Drug Discovery Software Market Forecast
10.5.3 Israel Drug Discovery Software Market Forecast
10.5.4 Turkey Drug Discovery Software Market Forecast
10.5.5 GCC Countries Drug Discovery Software Market Forecast
10.6 Global Drug Discovery Software Forecast by Type (2025-2030)
10.7 Global Drug Discovery Software Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Epocrates
11.1.1 Epocrates Company Information
11.1.2 Epocrates Drug Discovery Software Product Offered
11.1.3 Epocrates Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Epocrates Main Business Overview
11.1.5 Epocrates Latest Developments
11.2 MicroTracker
11.2.1 MicroTracker Company Information
11.2.2 MicroTracker Drug Discovery Software Product Offered
11.2.3 MicroTracker Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 MicroTracker Main Business Overview
11.2.5 MicroTracker Latest Developments
11.3 DrugPatentWatch
11.3.1 DrugPatentWatch Company Information
11.3.2 DrugPatentWatch Drug Discovery Software Product Offered
11.3.3 DrugPatentWatch Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DrugPatentWatch Main Business Overview
11.3.5 DrugPatentWatch Latest Developments
11.4 PEPID PDC
11.4.1 PEPID PDC Company Information
11.4.2 PEPID PDC Drug Discovery Software Product Offered
11.4.3 PEPID PDC Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PEPID PDC Main Business Overview
11.4.5 PEPID PDC Latest Developments
11.5 AtomWise
11.5.1 AtomWise Company Information
11.5.2 AtomWise Drug Discovery Software Product Offered
11.5.3 AtomWise Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AtomWise Main Business Overview
11.5.5 AtomWise Latest Developments
11.6 InSilicoTrials
11.6.1 InSilicoTrials Company Information
11.6.2 InSilicoTrials Drug Discovery Software Product Offered
11.6.3 InSilicoTrials Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 InSilicoTrials Main Business Overview
11.6.5 InSilicoTrials Latest Developments
11.7 Thermo Scientific
11.7.1 Thermo Scientific Company Information
11.7.2 Thermo Scientific Drug Discovery Software Product Offered
11.7.3 Thermo Scientific Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Scientific Main Business Overview
11.7.5 Thermo Scientific Latest Developments
11.8 AutoDock
11.8.1 AutoDock Company Information
11.8.2 AutoDock Drug Discovery Software Product Offered
11.8.3 AutoDock Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AutoDock Main Business Overview
11.8.5 AutoDock Latest Developments
11.9 CCD Vault
11.9.1 CCD Vault Company Information
11.9.2 CCD Vault Drug Discovery Software Product Offered
11.9.3 CCD Vault Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CCD Vault Main Business Overview
11.9.5 CCD Vault Latest Developments
11.10 Compound Assist
11.10.1 Compound Assist Company Information
11.10.2 Compound Assist Drug Discovery Software Product Offered
11.10.3 Compound Assist Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Compound Assist Main Business Overview
11.10.5 Compound Assist Latest Developments
11.11 DrugDev Spark
11.11.1 DrugDev Spark Company Information
11.11.2 DrugDev Spark Drug Discovery Software Product Offered
11.11.3 DrugDev Spark Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 DrugDev Spark Main Business Overview
11.11.5 DrugDev Spark Latest Developments
11.12 DSG Drug Safety
11.12.1 DSG Drug Safety Company Information
11.12.2 DSG Drug Safety Drug Discovery Software Product Offered
11.12.3 DSG Drug Safety Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 DSG Drug Safety Main Business Overview
11.12.5 DSG Drug Safety Latest Developments
12 Research Findings and Conclusion